{"name":"Woolsey Pharmaceuticals","slug":"woolsey-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"Woolsey Pharmaceuticals is a biotechnology company focused on the development of innovative treatments primarily in the area of cardiovascular diseases. The company has a pipeline of three drug candidates, all in Phase 2 clinical trials, which are based on the Rho kinase inhibitor fasudil.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0gJBVV95cUxPMVhacVdwVHVVNkdIRXlrTmJCV0lRU3EzdlZLdHZZWlBJT0ZTbDVvNUR4Y3o3cmdGRmtnamhJZEdMc3lybEZteGdrT2pYZUJFYm1WMnoxSUt2ejFJbmU1aGtWd2YtLW9fNFlXU1RZZ3dRbER4bDdBTWJudGFOY3NuUGswcHNrSF80TE80b0Njd3NjTTNQSlFvWXo1V1pEVEQ5elBjYVl4TTZWWXhxbTFOLXBZVU5xaF9BZmNGU3RGVjVHM0V0VEUxMFI3M3g5M0ZhR3lVM19XNUp2VnpubjFOWnRzTzk4cGwwVzJGdFNiZ3pVOUFXLWtDZkx6TkI0clR0OVhKUTdMSFlRdUpKQ3MtY2FCSlV5Y1p3V0lZbjNKOTRQZHFqRXhXTEYzbHc1M3UtMnhIMzBvSUlPVURzcHg5N3BrS1VseUVaVkg5NVQ5TTVSUQ?oc=5","date":"2026-03-04","type":"regulatory","source":"Barchart.com","summary":"Amyotrophic Lateral Sclerosis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | COSCIENS Biopharma, BenevolentAI, Verge Genomics, ProJenX - ","headline":"Amyotrophic Lateral Sclerosis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approval","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPRF84NDFRRjdhdlpRMmU1S2w4REtXczF5aXViM0J2MEdnMkNfSnlGaE9BSVUzMFp3MzhhMHZENFhQeVJtczdqcnNOSVhBZTM1Ymp3TVlqQUJodVVwSkFEUnR5bENuSmEtMjIzVXBJY2ljLU9hMktKSjR1S1VLbW9XclE3SlU1cTY3Y25BYlp2MnVSNnhVQTJlN1FTUXY?oc=5","date":"2025-03-06","type":"pipeline","source":"ALS News Today","summary":"Woolsey secures additional funding to advance ALS therapy Bravyl - ALS News Today","headline":"Woolsey secures additional funding to advance ALS therapy Bravyl","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxPdUtuMm1SVGZzbjBUQVVjWFljaUZRZm5fMU84T2Jxbmtib3E2NWxoc01tS0s3a2JmNE1WZXY4RVhGdTNqc01LTlZOQjdEb3VhbGV1cjM1NnBmOW5wUWdSaHlLNWJFRjFjbnFyWUNuVnQwMERZdl92MEJmMUhMZzBMS1hMN1JMZWZNY2JQbVJGNGNUZkFYTG9FN0FoLWFjak1ldmVodXNPcVFjT3RicXBMZXFFd01TbmRHMmRMMDZlQ0t3OXdzZWR4MnhOMlhNUGs?oc=5","date":"2025-02-27","type":"pipeline","source":"PR Newswire","summary":"Woolsey Pharmaceuticals Completes B Round Extension To Advance Its ALS Program - PR Newswire","headline":"Woolsey Pharmaceuticals Completes B Round Extension To Advance Its ALS Program","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxOVVhPVzRPc0ctNHc4YWtVQUpsRngxWlBXS2pZbkgzVXZhb01MR0trWFFKOFhKZ0EyMHp2TU0tS2QzeGEtQmdXM3BOd3N1anoxT0RPWHpvc0pxazFvUm9Kck0wb21PeU1yU29mTEZiWlY0TDJORWplQjRkNDBmTG82azFmQkFQQ0NYQnZ5UTBiM210VC1Cd1B1SnRBUU80dHhrYnRiVGp5eWdjMllOb0JQQkRDU1MtLUdURWwwUE5za2VPTTd5bUFpNy05LVNqcmx4VUpqelRINGx1aGZYWlhwQU5WamlMQ0NaTjBhcmJxZGxKUm5NVldOREp4dXBCRk1nNXpucUN4ZEJSVU45Y2x6dkZiNWhkNGxrQ2czcWdfeWpObWtDMzNVWjRR?oc=5","date":"2025-01-10","type":"patent","source":"PR Newswire","summary":"Woolsey Pharmaceuticals Secures Additional Key U.S. Patent Claims for BRAVYL® (oral fasudil) in Treating ALS, Including Reducing Neurofilament Light (NfL) - PR Newswire","headline":"Woolsey Pharmaceuticals Secures Additional Key U.S. Patent Claims for BRAVYL® (oral fasudil) in Treating ALS, Including ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAJBVV95cUxPU1VTRWJMMUZVUGstN0JBRnZTbWtYQnBXRDRtWWNOZHItQTVKM2FIcGRvZjVjSGJFM29LN2RfekZaTlpYamxZVkUtejZfUUFzZXJwODRCTi05NUJBNFBXWE43QU5sTHhqU2VIX0x3T0duQ0dSbTU4VVNsVFFFV3YyWTc5RzFpMWlKbUNWeU13UUNaS2tUdGVPOXZoNFc5UWF6RnN0U3ZSSlN2d2pORlVaR0lkQzdVcDZ0bjVwWHFONm5VZVF3M21WMzQxVGtEU2dIbDAzeURKbm5RSTF3RzhrR1I1Uk5wXzlBSlcyNElqRDQyQjYtUjJPUi1SYjBnTjctTF9TVTFGV0tFM3lvVWtHMFFxcElNS0VJUzk2dnUyZEF1ajlVWnhGWTNXUDgwN1JEWlNBaA?oc=5","date":"2024-12-09","type":"pipeline","source":"PR Newswire","summary":"Woolsey Pharmaceuticals Reveals Breakthrough Findings Showing Spread of Toxic TDP-43 Pathology Greatly Reduced in BRAVYL® (oral fasudil) Treated ALS Patients - PR Newswire","headline":"Woolsey Pharmaceuticals Reveals Breakthrough Findings Showing Spread of Toxic TDP-43 Pathology Greatly Reduced in BRAVYL","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gJBVV95cUxNR3JCQnhRWFJKakk0Ykwxd25Za2xkR2lvY1ZPbGNUR29BaDZiaHZ5TWRZbmxUUm9RaXNPWFNjaFduVUw5NHBZRmZWQ01KYnUwNlVlRzg3UFVZcWJ4eFpzNHk1VGZLNDd4OWwzUllQRkIyZFNsVzB5UDBNd3Q3OGFMQllCR2NDczdtaXhETmhhM0swQ2oxT1NRRnlvdkRQbzRGLWFJX3BqTXRXcHQya3ctdFJEYlc0YlAwdFo0bW1TMFNTQUhSb01scmI2SFYwN3RISDhRUU9yazBLWklLMU9nbEJINGdaa3QtdTh3d0dYdHVnY3R1b2FEZDFWcGk2YkdqX25yOVVNUC1xOVRVWDVKcl80NGgwc0ZwZW9MLUJLYjFmWkl6T1NOT1hXQ1h4eVlNNTVLVU9pWDB4bFBLVUdiSEMzT0wyZ0ZVMERyTmdYanlXWGhwbGc?oc=5","date":"2024-11-13","type":"trial","source":"GlobeNewswire","summary":"NLRP3 Protein Inhibitors Clinical Trial Pipeline Appears - GlobeNewswire","headline":"NLRP3 Protein Inhibitors Clinical Trial Pipeline Appears","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQNDVnUDRLaWxFU3J0NGR3MTJKNUFadWU0VGJPWkZMSW5hdTdKRWlBMXg2SFM4R1BqQUR5bzlZdTNBUHlYR2Z6bTZrTkhBNlBXWWVaTUVhZDFBWTI0TGJQWTRLQUx6S0pYelFwSEM4VHVwWFRfZkhkMlJIV1pZMnNFMVFwd0dsZzZRSXc?oc=5","date":"2024-10-28","type":"patent","source":"ALS News Today","summary":"Woolsey gets 3 US patents covering ROCK inhibitor Bravyl - ALS News Today","headline":"Woolsey gets 3 US patents covering ROCK inhibitor Bravyl","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPSGVjZkFuTlNMck0xYnVOZGRtUG5rUmpwb3MwdlZCdlhpTmlzUUpSNllTbDU0MXN4bjFKTm1QVUZ4ck1hcU0yd181QWVueWItV0ZyVlFpVnF0bnpFUEFOTVFXVUY4SHRTb3psSS1CYi0wZUpmY2dEMmpLcXctZ0szdmZDQzJCWkxTT21r?oc=5","date":"2024-06-24","type":"pipeline","source":"ALS News Today","summary":"ROCK inhibitor Bravyl shows early signs of efficacy for ALS - ALS News Today","headline":"ROCK inhibitor Bravyl shows early signs of efficacy for ALS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE9YV3hIZ0JZZHRiT3VUX0lsc3h0TVB3SktBRzRaTHJhUUlKMVAyM1JIMF8zaERyUGVqcGdpdUxrUG8tbE9DMHJGQnF6elhfQXEwdEZxTHZrdjd6S2pHaGRlTkthbi1sY09JWHB0SUpLYjBUWkhz?oc=5","date":"2024-06-20","type":"trial","source":"Clinical Trials Arena","summary":"Woolsey Pharmaceuticals’ BRAVYL shows promise in Phase IIa ALS trial - Clinical Trials Arena","headline":"Woolsey Pharmaceuticals’ BRAVYL shows promise in Phase IIa ALS trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gJBVV95cUxORGstaFZtZy1ULWd4MW5EeFA4cHRKajhjWFhyRlUzd2ZFT0JLUVdudUxaUXUwQTJLWXBPNWl6cXpEb0J5M05oMVFjbXRGN2w0Vnp0cWdqdDAxV3pQUWNSdENkZmk1aHVNdkZ3dXJILTRlNnExd0UxZU5WVnZSYlMzQmUtT19JeXpSZjZndlM3ZmUtSlJGbWczZVlQTG50TzU3WXZuS0RwaVZGN1FrR0VmV1FHeGhHZmw2R3VmM2Z2bC13NnRxSzJOc2J4TGVTdU9FRkRIMlNoTF80WGdvMTEyT0V4UVJZbS1ldUhIVy1Vc3V4NkoyQ08yNEo4UmhOcDdsTmJ3NkM2SEoxdDlVMjBMZkEweU5mbjNHQ1M2NGlTUFMxUzRPb28tSFVRYlA0a0x3R0FqeEdfS1NaQjY5QmNnb2xYMmFwTU5FbzA2M2gzekwwV3pOeFFCTG5nakR2QQ?oc=5","date":"2024-06-19","type":"trial","source":"PR Newswire","summary":"Results of Woolsey Pharmaceuticals' Phase 2a Study of BRAVYL in ALS Patients Shows Statistically Significant Reduction in Neurofilament Light and Directionally Improved Clinical Outcomes - PR Newswire","headline":"Results of Woolsey Pharmaceuticals' Phase 2a Study of BRAVYL in ALS Patients Shows Statistically Significant Reduction i","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQUHJXYkxKV0licEktU1k4Qy1sV3dNRWh1TkUzSUNyS3k4WEpYbFg4dERXd3JQWEdSeUItR3VvZjVIM3Zsd29MOEViNmdZTENOREhWX1dobTVEbHBIaGtKZHg5Rzl3WGZYVGN1cW9FWWlUTkd4QVFRZi1FYjBEVmgwWjhRVGMtTTNiT2NUNkZR?oc=5","date":"2024-05-29","type":"pipeline","source":"University of Hawaii at Hilo","summary":"UH Hilo pharmacy college Class of 2024 celebrates achievements - University of Hawaii at Hilo","headline":"UH Hilo pharmacy college Class of 2024 celebrates achievements","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQSkd1Tlpzc24zTEpKOFhGVUgtWGVSeDE2VFlGZ0tYNkVXemI5NlJFRE1GWVUzRXFsaHBQeEtRWG9tY1pvQ0xoelNwcGY3QmFBSklvZWhSNlItcGNreWFKQmQwb1hHR0t5MW5qcS1EQWRQZXpjenUtOHltVms3UDcxbFZ3bTk3bm00Zmc?oc=5","date":"2023-05-12","type":"pipeline","source":"University of Hawaii at Hilo","summary":"UH Hilo Daniel K. Inouye College of Pharmacy celebrates 2023 Spring Awards - University of Hawaii at Hilo","headline":"UH Hilo Daniel K. Inouye College of Pharmacy celebrates 2023 Spring Awards","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}